E-LIB Suche - Ergebnisse für: Seibold, F

1

P561 Reasons for low use of topical 5-ASA formulations in p..:

Pittet, V ; Rogler, G ; Seibold, F
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1098-i1098 , 2024

2

P1132 Fecal incontinence in Inflammatory Bowel Disease (IBD..:

Hammond, P ; Marques Santos, J D M S ; Alhassan, J..
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2028-i2028 , 2024

Link: https://doi.org/10.1093/..

3

P559 SARS-CoV-2 vaccination does not increase the risk for ..:

Rossier, L ; Seibold, F
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i690-i691 , 2023

Link: https://doi.org/10.1093/..

4

P181 IBD patients with early clinical and sonographic impro..:

Kucharzik, T ; Helwig, U ; Seibold, F...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i247-i248 , 2022

Link: https://doi.org/10.1093/..

5

P279 Potential of managed care programmes for patients with..:

Bokemeyer, B ; Kaiser, C ; Primas, C...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S310-S313 , 2021

Link: https://doi.org/10.1093/..

6

A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY ..:

Feagan, B G ; Loftus Jr, E V ; Danese, S...
Journal of the Canadian Association of Gastroenterology. 4 (2021) Supplement_1 - p. 18-20 , 2021

Link: https://doi.org/10.1093/..

7

P662 Remission to vedolizumab is not higher in TNF-naïve co..:

Biedermann, L ; Mader, O ; Hruz, P...
Journal of Crohn's and Colitis. 13 (2019) Supplement_1 - p. S450-S451 , 2019

Link: https://doi.org/10.1093/..

8

P581 Patient-reported complementary and alternative medicin..:

Pittet, V ; Aslan, N ; Fournier, N...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S401-S402 , 2018

Link: https://doi.org/10.1093/..

9

P569 Sequential rescue treatments in steroid refractory ulc..:

Protic, M. ; Seibold, F. ; Manser, C....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S370-S370 , 2017

Link: https://doi.org/10.1093/..

10

Systematic analysis of factors associated with progression ..:

Safroneeva, E. ; Vavricka, S. ; Fournier, N....
Alimentary Pharmacology & Therapeutics. 42 (2015) 5 - p. 540-548 , 2015

Link: https://doi.org/10.1111/..

11

Topical therapy is underused in patients with ulcerative co..:

Seibold, F. ; Fournier, N. ; Beglinger, C....
Journal of Crohn's and Colitis. 8 (2014) 1 - p. 56-63 , 2014

Link: https://doi.org/10.1016/..

12

P131 Systematic analysis of factors associated with progres..:

Safroneeva, E. ; Vavricka, S. ; Fournier, N....
Journal of Crohn's and Colitis. 8 (2014) - p. S116-S117 , 2014

Link: https://doi.org/10.1016/..

13

P423 Long term outcome for sequential rescue treatments in ..:

Protic, M. ; Seibold, F. ; Shoepfer, A....
Journal of Crohn's and Colitis. 8 (2014) - p. S242 , 2014

Link: https://doi.org/10.1016/..

14

P141 Serum ficolin-2 correlates worse than fecal calprotect..:

Schoepfer, A. ; Schaffer, T. ; Seibold, F.
Journal of Crohn's and Colitis. 8 (2014) - p. S120-S121 , 2014

Link: https://doi.org/10.1016/..

15

P383 Response rates and side effects after 26 weeks of tacr..:

Protic, M. ; Frei, P. ; Radojicic, Z....
Journal of Crohn's and Colitis. 7 (2013) - p. S163 , 2013

Link: https://doi.org/10.1016/..